Using these models, we found that co-expression of CXCR1 and CXCR2 with an αvβ6-specific CAR resulted in a significant increase in T-cell migration towards recombinant or tumor-derived IL-8, without alteration of CAR-mediated cytolytic activity or cytokine release. Here, CXCR2 is linked to neoplasm.